Photodynamic Therapy—Current Limitations and Novel Approaches
Open accessThe DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Abstract
Photodynamic therapy (PDT) mostly relies on the generation of singlet oxygen, via the excitation of a photosensitizer, so that target tumor cells can be destroyed. PDT can be applied in the settings of several malignant diseases. In fact, the earliest preclinical applications date back to 1900’s. Dougherty reported the treatment of skin tumors by PDT in 1978. Several further studies around 1980 demonstrated the effectiveness of PDT. Thus, the technique has attracted the attention of numerous researchers since then. Hematoporphyrin derivative received the FDA approval as a clinical application of PDT in 1995. We have indeed witnessed a considerable progress in the field over the last century. Given the fact that PDT has a favorable adverse event profile and can enhance anti-tumor immune responses as well as demonstrating minimally invasive characteristics, it is disappointing that PDT is not broadly utilized in the clinical setting for the treatment of malignant and/or non-malignant diseases. Several issues still hinder the development of PDT, such as those related with light, tissue oxygenation and inherent properties of the photosensitizers. Various photosensitizers have been designed/synthesized in order to overcome the limitations. In this Review, we provide a general overview of the mechanisms of action in terms of PDT in cancer, including the effects on immune system and vasculature as well as mechanisms related with tumor cell destruction. We will also briefly mention the application of PDT for non-malignant diseases. The current limitations of PDT utilization in cancer will be reviewed, since identifying problems associated with design/synthesis of photosensitizers as well as application of light and tissue oxygenation might pave the way for more effective PDT approaches. Furthermore, novel promising approaches to improve outcome in PDT such as selectivity, bioengineering, subcellular/organelle targeting, etc. will also be discussed in detail, since the potential of pioneering and exceptional approaches that aim to overcome the limitations and reveal the full potential of PDT in terms of clinical translation are undoubtedly exciting. A better understanding of novel concepts in the field (e.g.enhanced, two-stage, fractional PDT) will most likely prove to be very useful for pursuing and improving effective PDT strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
GSH and H2O2 Co‐Activatable Mitochondria‐Targeted Photodynamic Therapy under Normoxia and Hypoxia
Sun, J., Du, K., Diao, J., Cai, X., Feng, F., & Wang, S. (2020) · Angewandte Chemie · doi:10.1002/ange.202003895 · Cited by 78
Fingar, V. H., Wieman, T. J., & Haydon, P. S. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb03182.x · Cited by 77
A Theoretical Study of Light Fractionation and Dose-Rate Effects in Photodynamic Therapy
Pogue, B. W., & Hasan, T. G. (1997) · Radiation Research · doi:10.2307/3579621 · Cited by 75
A C5N2 Nanoparticle Based Direct Nucleus Delivery Platform for Synergistic Cancer Therapy
Chen, W., Liu, J., Wang, Y., Jiang, C., Yu, B., Sun, Z., & Lu, L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900884 · Cited by 75
Tumor‐Activated Photosensitization and Size Transformation of Nanodrugs
Wang, Y., Shi, L., Wu, W., Qi, G., Zhu, X., & Liu, B. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010241 · Cited by 75
Zhang, S., Yang, L., Ling, X., Shao, P., Wang, X., Edwards, W. B., & Bai, M. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.033 · Cited by 74
Xue, L., Chiu, S., Fiebig‐Comyn, A., Andrews, D. W., & Oleinick, N. L. (2003) · Oncogene · doi:10.1038/sj.onc.1207019 · Cited by 69
Erbaş-Çakmak, S., Cakmak, F. P., Topel, S. D., Uyar, T. B., & Akkaya, E. U. (2015) · Chemical Communications · doi:10.1039/c5cc01261a · Cited by 69
Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy
Li, Y., Wang, J., Zhang, X., Guo, W., Li, F., Yu, M., Kong, X., Wu, W., & Hong, Z. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01035g · Cited by 66
Castaño, A. P., Liu, Q., & Hamblin, M. R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602953 · Cited by 66
The Mode of Cell Death Induced by Photodynamic Treatment Depends on Cell Density
Dahle, J., Steen, H. B., & Moan, J. E. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb08150.x · Cited by 66
Xiao, Q., Lin, H., Wu, J., Pang, X., Zhou, Q., Jiang, Y., Wang, P., Leung, A. W., Lee, H., Jiang, S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00280 · Cited by 66
Recent Advances in Self-Exciting Photodynamic Therapy
Blum, N. T., Zhang, Y., Qu, J., Lin, J., & Huang, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.594491 · Cited by 66
Mitochondrial Effects of Triarylmethane Dyes
Kowaltowski, A. J., Turin, J., Indig, G. L., & Vercesi, A. E. (1999) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005421112345 · Cited by 65
Chen, D., Tao, R., Tao, K., Chen, B., Choi, S. K., Tian, Q. C., Xu, Y., Zhou, G., & Sun, K. (2017) · Small · doi:10.1002/smll.201602053 · Cited by 65
Cooperative tumour cell membrane targeted phototherapy
Kim, H., Lee, J., Oh, C., & Park, J. (2017) · Nature Communications · doi:10.1038/ncomms15880 · Cited by 65
Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶
Huang, Z. W., Chen, Q., Shakil, A., Chen, H., Beckers, J., Shapiro, H., & Hetzel, F. W. (2003) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2003)0780496hettck2.0.co2 · Cited by 64
Nguyen, V.-N., Baek, G., Qi, S., Heo, S., Yim, Y., & Yoon, J. (2020) · Dyes and Pigments · doi:10.1016/j.dyepig.2020.108265 · Cited by 62
Guo, H.-W., Lin, L., Chen, P.-H., Ho, M., Huang, W., Lee, Y., Chiou, S., Hsieh, Y., Dong, C., & Wang, H.-W. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.04.007 · Cited by 60
Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy
Fingar, V. H., Wieman, T. J., Park, Y. J., & Henderson, B. W. (1992) · Journal of Surgical Research · doi:10.1016/0022-4804(92)90101-5 · Cited by 60
Effects of Photodynamic Therapy on Tumor Stroma
Peng, Q., & Nesland, J. M. (2004) · Ultrastructural Pathology · doi:10.1080/01913120490515586 · Cited by 60
Proof-of-principle for two-stage photodynamic therapy: hypoxia triggered release of singlet oxygen
Ayan, S., Günaydın, G., Yeşilgül, N., Gedik, M. E., Seven, Ö., & Akkaya, E. U. (2020) · Chemical Communications · doi:10.1039/d0cc06031c · Cited by 60
Self-citationTumor Oxygenation Changes Post‐Photodynamic Therapy
Chen, Q., Chen, H., & Hetzel, F. W. (1996) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1996.tb03003.x · Cited by 58
Molecular demultiplexer as a terminator automaton
Turan, I. S., Günaydın, G., Ayan, S., & Akkaya, E. U. (2018) · Nature Communications · doi:10.1038/s41467-018-03259-z · Cited by 58
Self-citationYom, S. S., Busch, T. M., Friedberg, J. S., Wileyto, E. P., Smith, D., GLATSTEIN, E. J., & Hahn, S. M. (2003) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2003)0780075esclim2.0.co2 · Cited by 57
Wang, D., Zhu, L. H., Pu, Y., Wang, J., Chen, J., & Dai, L. (2017) · Nanoscale · doi:10.1039/c7nr03019c · Cited by 57
Xiao, Z. J., Halls, S., Dickey, D. J., TULIP, J., & Moore, R. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1561 · Cited by 56
Photodynamic Effect on DNA and Cell Survival of Human Cells Sensitized by Hematoporphyrin
Moan, J. E., & Boye, E. (1981) · Photobiochemistry and photobiophysics. · doi:10.1016/s0165-8646(24)00257-5 · Cited by 56
Non-Oncologic Applications of Nanomedicine-Based Phototherapy
Yoo, S. W., Oh, G., Ahn, J., & Chung, E. (2021) · Biomedicines · doi:10.3390/biomedicines9020113 · Cited by 56
Approaches to improve photodynamic therapy of cancer
Firczuk, M. (2011) · Frontiers in Bioscience · doi:10.2741/3684 · Cited by 55 · cited 3×
“, Kong, D., Cheng, X., and Liu, B. (2018). Multifunctional Liposome: A Bright AIEgen-Lipid Conjugate with Strong Photosensitization.”
BackgroundInfluentialHendrzak‐Henion, J. A., Knisely, T. L., Cincotta, L., Cincotta, E., & Cincotta, A. H. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb03330.x · Cited by 55
Rubio, N., Fleury, S. P., & Redmond, R. W. (2009) · Photochemical & Photobiological Sciences · doi:10.1039/b815343d · Cited by 53
Kim, J., Tung, C., & Choi, Y. (2014) · Chemical Communications · doi:10.1039/c4cc04166f · Cited by 53
Immunomodulatory aspects of photodynamic therapy
Hunt, D. W. C., & Levy, J. G. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.1.57 · Cited by 53
Chan, W. S., Brasseur, N., Madeleine, C. L., & van Lier, J. E. (1996) · PubMed · Cited by 52
Fang, I., Slowing, I. I., Wu, K. C. ‐., Lin, V. S. ‐., & Trewyn, B. G. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200023 · Cited by 52
Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply
Korbelik, M., & Krosl, G. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.358 · Cited by 51
Promotion of Proapoptotic Signals by Lysosomal Photodamage
Kessel, D. H., & Reiners, J. J. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12456 · Cited by 51
Ling, D., Bae, B.-C., Park, W., & Na, K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.023 · Cited by 50
Zheng, J., Liu, Y., Song, F., Jiao, L., Wu, Y., & Peng, X. (2020) · Chemical Communications · doi:10.1039/d0cc02019b · Cited by 50
Inanami, O., Yoshito, A., Takahashi, K., Hiraoka, W., & Kuwabara, M. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb08265.x · Cited by 50
Yamamoto, N., Homma, S., Sery, T. W., Donoso, L. A., & Hoober, J. K. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90388-t · Cited by 49
Chaloupka, R., Obšil, T., Plášek, J., & Sureau, F. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00016-4 · Cited by 47
Karaman, O., Almammadov, T., Gedik, M. E., Günaydın, G., Kölemen, S., & Gunbas, G. E. (2019) · ChemMedChem · doi:10.1002/cmdc.201900380 · Cited by 47
Self-citationKang, J. H., & Ko, Y. T. (2019) · Biomaterials Science · doi:10.1039/c9bm00403c · Cited by 46
Allman, R., Cowburn, P., & Mason, M. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1328 · Cited by 45
Qiao, L., Liu, J., Han, Y., Wei, F., Liao, X., Zhang, C., Xie, L., Ji, L., & Chao, H. (2021) · Chemical Communications · doi:10.1039/d0cc06926d · Cited by 45
Fran�ois, A. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1174 · Cited by 43
Gardner, L. C., Smith, S. J., & Cox, T. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54738-4 · Cited by 43
Gad, F., Viau, G., Bousbira, M., Bertrand, R., & Bissonnette, R. (2001) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540100500103 · Cited by 41
Photodynamic Therapy Targets the mTOR Signaling Network in Vitro and in Vivo
Weyergang, A., Berg, K., Kaalhus, O., Peng, Q., & Selbo, P. K. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800156e · Cited by 39
Photodynamic therapy in dermatology: Beyond current indications
Queirós, C. S., Garrido, P. M., Silva, J. M., & Filipe, P. (2020) · Dermatologic Therapy · doi:10.1111/dth.13997 · Cited by 39
de Bruijn, H. S., Brooks, S., den Heuvel, A. V. D. P., ten Hagen, T. L. M., de Haas, E. R. M., & Robinson, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148850 · Cited by 36
An Activatable Photosensitizer Targeting Human NAD(P)H: Quinone Oxidoreductase 1
Digby, E. M., Sadovski, O., & Beharry, A. A. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201904607 · Cited by 36
Erkiert‐Polguj, A., Halbina, A., Polak-Pacholczyk, I., & Rotsztejn, H. (2016) · Journal of Cosmetic and Laser Therapy · doi:10.3109/14764172.2015.1114635 · Cited by 32
Niu, N., Zhou, H., Liu, N., Jiang, H., Hussain, E., Hu, Z., & Yu, C. (2018) · Chemical Communications · doi:10.1039/c8cc09396b · Cited by 32
Schmidt, S., Wagner, U. A. G., Oehr, P., et al. (1992) · PubMed · Cited by 31
Poudel, K., Banstola, A., Gautam, M., Soe, Z. C., Pham, L. M., Jeong, J., Choi, H., Ku, S., Yong, C. S., Tran, T. H., et al. (2020) · Nanoscale · doi:10.1039/d0nr07736d · Cited by 30
Light scattering from cells: the contribution of the nucleus and the effects of proliferative status
Mourant, J. R., Murat Canpolat, A., Brocker, C., Esponda-Ramos, O., Johnson, T. M., Matanock, A., STETTER, K. O., & Freyer, J. P. (2000) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.382747 · Cited by 28
Özdemir, T., Lu, Y., Kölemen, S., Tanriverdi‐Ecik, E., & Akkaya, E. U. (2017) · ChemPhotoChem · doi:10.1002/cptc.201600049 · Cited by 28
Uçar, E., Seven, Ö., Lee, D., Kim, G., Yoon, J., & Akkaya, E. U. (2019) · ChemPhotoChem · doi:10.1002/cptc.201800231 · Cited by 26
Devi, L. R., Raza, M. K., Musib, D., Ramu, V., Devi, J., & Roy, M. (2019) · Inorganica Chimica Acta · doi:10.1016/j.ica.2019.119208 · Cited by 24
Self-reporting heavy atom-free photodynamic therapy agents
Turkoglu, G., Koygun, G. K., Yurt, M. N. Z., Demirok, N., & Erbaş-Çakmak, S. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01944e · Cited by 23
Assikar, S., Labrunie, A., Kérob, D., Couraud, A., & Bédane, C. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16208 · Cited by 21
Musser, D. A., & Oseroff, A. R. (2001) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0730518cotiib2.0.co2 · Cited by 20
Autoinhibitory Feedback Control over Photodynamic Action
Yurt, M. N. Z., Çakmak, Y., Tekin, G., Karakurt, S., & Erbaş-Çakmak, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b01410 · Cited by 17
Exploiting the Cellular Redox‐Control System for Activatable Photodynamic Therapy
Gharibi, N., Kailass, K., & Beharry, A. A. (2018) · ChemBioChem · doi:10.1002/cbic.201800585 · Cited by 15
Daylight-Photodynamic Therapy for the Treatment of Actinic Keratosis in Different Seasons.
Cantisani, C., Paolino, G., Bottoni, U., & Calvieri, S. (2015) · PubMed · Cited by 14
Rousseau, J., Nakamura, M., Rio‐Maior, H., Álvares, F., Choquet, R., de Carvalho, L. M., Godinho, R., & Santos, N. (2021) · Pathogens · doi:10.3390/pathogens10020243 · Cited by 14
A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy
Fan, J. H., Fan, G., Yuan, P., Deng, F., Liu, L., Zhou, X., Yu, X. Y., Cheng, H. B., & Li, S. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00868 · Cited by 10
Cited by
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402
“Targeting overexpressed enzymes in tumor cells in contrast to normal cells is an encouraging approach in order to generate ROS specifically in tumor cells (Gunaydin et al., 2021).”
BackgroundSelf-citationAlfei, S., Schito, G. C., Schito, A. M., & Zuccari, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137182 · Cited by 302
Cheng, H., Cao, X., Zhang, S., Zhang, K., Cheng, Y., Wang, J., Zhao, J., Zhou, L., Liang, X., & Yoon, J. (2023) · Advanced Materials · doi:10.1002/adma.202207546 · Cited by 260
Lee, J.-H., Yang, S.-B., Park, S. J., Kweon, S., Ma, G., Seo, M., Kim, H. R., Kang, T.-B., Lim, J.-H., & Park, J. (2025) · ACS Nano · doi:10.1021/acsnano.4c16128 · Cited by 37
Daylight-PDT: Everything under the Sun
Beiki, D., Eggleston, I. M., & Pourzand, C. (2022) · Biochemical Society Transactions · doi:10.1042/bst20200822 · Cited by 31
Metadata
- Authors
- Gunaydin, G., Gedik, M. E., & Ayan, S.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2021-06-10
- Volume
- 9
- Pages
- 691697-691697
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W3172022498
- Cited by
- 599
- References
- 270
- FWCI
- 51.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.